SN6
SHORT NOTE
5M
★ High-yield
Describe central serous chorioretinopathy and macular hole.
Central Serous Chorioretinopathy
Central serous chorioretinopathy (CSCR) is a localised serous detachment of the neurosensory retina at the macula, caused by leakage through a defective retinal pigment epithelium over a thickened, hyperpermeable choroid.
- The classical patient is a young or middle-aged male, often with a driven, "type A" personality, under stress
- The single most important association IS corticosteroid exposure, by any route — oral, inhaled, nasal, topical skin creams, intra-articular and intravenous. It must be asked about explicitly, because patients do not regard creams and inhalers as drugs, and stopping the steroid is often the whole treatment
- Other associations — endogenous hypercortisolism (Cushing syndrome); pregnancy, in which it resolves after delivery; sympathomimetics; obstructive sleep apnoea; Helicobacter pylori; and psychological stress
Macular Hole and Epiretinal Membrane
- A full-thickness macular hole is a defect of the neurosensory retina at the fovea, caused by anteroposterior and tangential vitreomacular traction as the vitreous separates
- an idiopathic condition of women in the sixth and seventh decades; also follows trauma and high myopia
- Symptoms — gradual central blurring, metamorphopsia and a central scotoma; acuity falls to around 6/60
- GASS staging — stage 1, impending hole with a foveal cyst and loss of the foveal depression; stage 2, a small full-thickness hole; stage 3, a full hole over 400 micrometres with the vitreous still attached; stage 4, a full hole with complete posterior vitreous detachment
- The WATZKE-ALLEN test — a narrow slit beam across the fovea appears broken or thinned to the patient in a full-thickness hole, and merely distorted in a pseudohole. OCT is now diagnostic and has replaced clinical staging
- Differential — a lamellar hole (partial thickness); a pseudohole in an epiretinal membrane, in which the retina is intact but the membrane creates the appearance of a hole; and vitreomacular traction
- Treatment — pars plana vitrectomy with internal limiting membrane peeling and gas tamponade, with face-down posturing afterwards. Closure rates exceed 90%, and the outcome depends on the duration and size of the hole, so referral should not be delayed. Ocriplasmin is an enzymatic alternative for selected small holes with traction
- Epiretinal membrane (macular pucker, cellophane maculopathy) — a fibrocellular sheet on the internal limiting membrane which contracts and wrinkles the retina. idiopathic in most, following posterior vitreous detachment; or secondary to retinal tear or detachment surgery, vein occlusion, uveitis, diabetes or trauma
All questions in The Retina and Vitreous
- Q1Describe the anatomy and physiology of the retina and the vitreous. ★
- Q2Describe diabetic retinopathy with its classification and management. ★
- Q3Describe the retinal vascular occlusions with their management. ★
- Q4Describe retinal detachment with its types, features and management. ★
- Q5Describe age-related macular degeneration with its management. ★
- SN1Describe retinitis pigmentosa with its features and associations. ★
- SN2Describe retinopathy of prematurity with its screening and treatment. ★
- SN3Describe hypertensive retinopathy and the other systemic retinopathies. ★
- SN4Describe posterior vitreous detachment, vitreous haemorrhage and vitreous opacities. ★
- SN5Describe retinoblastoma with its genetics, presentation and management. ★
- SN6Describe central serous chorioretinopathy and macular hole. ★
- SN7Describe the investigations used in retinal disease.